from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3483c/-

LFCtreatmentdescriptionclass of inhibitor

-0.266

Amikacinug/mL Amikacintranslation

-0.688

Cap5-10ug/mL Capreomycintranslation

-0.616

Rox10-50 ug/mL Roxithromycintranslation

-0.331

SM2-5 ug/mL Streptomycintranslation

-0.510

Tet5-10 ug/mL Tetracyclinetranslation

-0.015

Rif0.2-5ug/mL Rifampicintranscription

0.969

Rifp0.1-0.5ug/mL Rifapentinetranscription

-0.028

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.270

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.305

CPZ10-50 ug/mL Chlorpromazinerespiration

0.897

Clofazimine10-13 ug/mL Clofaziminerespiration

0.214

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.079

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.626

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.756

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.287

Econazole10-24 ug/mL Econazole (azole drug)respiration

-0.038

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.492

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

0.529

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

0.021

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-0.803

KCN5-20 ug/mL Potassium cyaniderespiration

-0.379

NaN30.2-2 mM Sodium aziderespiration

0.178

Nigericin50 uM Nigericinrespiration

0.030

TRC10-150 ug/mL Triclosanrespiration

0.349

TRZ10-25 ug/mL Thioridazinerespiration

0.687

Valinomycin0.5-10 uM Valinomycinrespiration

-0.747

ZnSO42 mM ZnSO4respiration

0.027

menadione6-10 ug/mL Menadionerespiration

0.217

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.239

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.967

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.534

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.180

NRP_1Non-replicating persistence stage 1dosRassociated

-0.633

Amp0.2mg/mL AmpicillincellWall

0.076

Cephalexin20-100 ug/mL CephalexincellWall

0.341

Cerulenin0.32-5 ug/mL CerulenincellWall

-1.060

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.517

EMB10-20 ug/mL EthambutolcellWall

0.397

Eta12-40 ug/mL EthionamidecellWall

0.095

INH0.2-0.4 ug/mL IsoniazidcellWall

0.461

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.975

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.451

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.643

BZA0.12 mg/mL BenzamidearomaticAmides

-0.376

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.279

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

1.268

H2O24 mM hydrogen peroxideDNAdamaging

0.232

Levo10 ug/mL LevofloxacinDNAdamaging

0.068

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

0.269

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.285

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.671

UVUV-irradiationDNAdamaging

0.422

ARP41-4 ug/mL Antitubercular compound ARP4?

0.544

Antimycin12.5-50 ug/mL Antimycin A?

-0.308

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.485

PA_110-50 ug/mL Antitubercular compound PA-1?

0.587

PA_2110-50 ug/mL Antitubercular compound PA-21?

-0.713

PA8240.2-2 ug/mL PA-824?

0.384

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.502

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.485

Verapamil50 uM Verapamil?

0.239

mercaptoethanol2 mM 2-Mercaptoethanol?

0.535

methoxatin10-20 ug/mL Methoxatin?